Grundläggande statistik
| CIK | 1125699 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Dais Corporation
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Tra |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 10, 2024 DAIS CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-1760865 (State or Other Jurisdiction of Incorporation or Organization) (Co |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact name |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact nam |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-53554 DAIS CORPORATIO |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Tra |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ |
|
| January 11, 2023 |
DLYT / Dais Analytic Corp / GS Capital Partners, LLC Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment No. Under the Securities Exchange Act of 1934 Dais Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 234044204 (CUSIP Number) January 10, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact |
|
| November 15, 2022 |
NT 10-Q 1 dlytnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0212 Estimated average burden hours per response 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 20 |
|
| August 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2022 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact name |
|
| August 15, 2022 |
NT 10-Q 1 dlytnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0212 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☒ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 202 |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2022 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact nam |
|
| May 17, 2022 |
NT 10-Q 1 dlytnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Pe |
|
| April 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-53554 DAIS CORPORATIO |
|
| April 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2022 DAIS CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-1760865 (State or Other Jurisdiction of Incorporation or Organization) (Co |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: March 31, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2021 ? |
|
| January 5, 2022 |
Exhibit 99.1 CUSIP No. 234044204 13G JOINT FILING AGREEMENT The undersigned, the Reporting Persons named in Schedule 13G, hereby agree that this Schedule 13G is filed on behalf of them and that each Reporting Person is responsible for the timely filing of any other amendments to the Schedule 13G. Each Reporting Person further agrees that each of them is responsible for the completeness and accurac |
|
| January 5, 2022 |
DLYT / Dais Analytic Corp / BHP Capital NY, Inc. - FORM 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DAIS Corp (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 234044204 (CUSIP Number) BHP Capital NY, Inc. Bryan Pantofel 45 SW 9th Street, Suite 1603, Miami, Florida 33130 (516) 780-4240 (Name, Address and Telephone N |
|
| January 5, 2022 |
Exhibit 99.2 CUSIP No. 234044204 13G POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS BHP CAPITAL NY, INC. (?BHP?) does hereby make, constitute and appoint Bryan Pantofel its true and lawful attorney, to execute and deliver in its name and on its behalf whether BHP acting individually or as representative of others, any and all filings required to be made by BHP under the Securities Exchange A |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact |
|
| October 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact name |
|
| September 30, 2021 |
Letter of RBSM LLP dated September 30, 2021 EXHIBIT 16.1 805 Third Avenue Suite 1430 New York, New York 10022-7513 212.868.3669 212.838.2676 / Fax www.rbsmllp.com September 30, 2021 Securities and Exchange Commission 100 F Street, N.W. Washington, DC 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Dais Analytic Corporation (the ?Company?) Form 8-K dated September 30, 2021, and are in agreement with the statements relating only to RBS |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact nam |
|
| September 30, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2021 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or Organ |
|
| September 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A 10-K/A 1 dlyt10ka.htm FORM 10-KA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission fi |
|
| September 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-53554 DAIS CORPORATIO |
|
| August 6, 2021 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 DAIS CORPORATION (Exact name of Registrant as specified in its charter) New York 000-53554 14-1760865 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2021 ☐ |
|
| March 31, 2021 |
NT 10-K 1 dlytnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For |
|
| November 23, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 202 |
|
| August 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2020 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact name |
|
| August 12, 2020 |
EXHIBIT 10.15 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of August 17, 2015 (the “Effective Date”), by and between: (i) Dais Analytic Corporation, a Florida corporation (the “Company”) and (ii) Brian C. Johnson, an individual (hereinafter referred to as “Employee”). The Company and Employee may be referred to hereinafter individually as a “Party” |
|
| August 12, 2020 |
EXHIBIT 3.11 1 2 3 |
|
| August 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-5 |
|
| August 10, 2020 |
8-K 1 dlyt8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2020 DAIS CORPORATION (Exact name of Registrant as specified in its charter) New York 000-53554 14-1760865 (State or other jurisdiction of inco |
|
| July 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2020 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact nam |
|
| June 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2020 ¨ |
|
| June 2, 2020 |
EXHIBIT 10.15 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of August 17, 2015 (the “Effective Date”), by and between: (i) Dais Analytic Corporation, a Florida corporation (the “Company”) and (ii) Brian C. Johnson, an individual (hereinafter referred to as “Employee”). The Company and Employee may be referred to hereinafter individually as a “Party” |
|
| June 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-53554 DAIS CORPORATIO |
|
| June 2, 2020 |
EXHIBIT 3.11 1 2 3 |
|
| May 15, 2020 |
8-K 1 dlyt8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 DAIS CORPORATION (Exact name of Registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorpo |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ☒ Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2019 |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2020 DAIS CORPORATION (Exact name of Registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdictionof incorporation) (CommissionFile N |
|
| March 24, 2020 |
8-K 1 dlyt8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2020 DAIS CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorpora |
|
| December 11, 2019 |
Certificate of Amendment of the Certificate of Incorporation EXHIBIT 3.1 |
|
| December 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 5, 2019 DAIS CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or Organization) (C |
|
| December 11, 2019 |
EXHIBIT 99.1 Company Completes Reverse Stock Split, Nears Agreement with Debtholders to Deleverage Balance Sheet and Forges Strategic Relationship Focused on Industrial/Consumer Food Packaging ODESSA, FL, Dec. 05, 2019 (GLOBE NEWSWIRE) - via NEWMEDIAWIRE - Dais Corporation (“Dais” or the “Company”) (OTC: DLYT-D), is executing on plans to grow revenues from product sales which embody the Company’s |
|
| December 2, 2019 |
DLYT / Dais Analytic Corp. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CO |
|
| December 2, 2019 |
DLYT / Dais Analytic Corp. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS COR |
|
| December 2, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event Reported): November 7, 2019 DAIS CORPORATION (Exact Name of Registrant as Specified in Charter) New York 000-53554 14-1760865 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| December 2, 2019 |
DLYT / Dais Analytic Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact |
|
| November 14, 2019 |
DLYT / Dais Analytic Corp. NT 10-Q - - NT 10-Q NT 10-Q 1 dlytnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For |
|
| October 16, 2019 |
DLYT / Dais Analytic Corp. DEFR14C - - DEFR 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Amendment No. 2 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement DAIS CORPORATION (Na |
|
| August 23, 2019 |
DLYT / Dais Analytic Corp. DEFR14C - - DEFR 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Amendment No. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement DAIS CORPORATION (Na |
|
| August 22, 2019 |
DLYT / Dais Analytic Corp. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Amendment No. 1 x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORA |
|
| August 19, 2019 |
DLYT / Dais Analytic Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact name |
|
| August 14, 2019 |
DLYT / Dais Analytic Corp. NT 10-Q - - NT 10-Q NT 10-Q 1 dlytnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q x Form 10-D ¨ Form N-SAR ¨ Form N-CSR ¨ For |
|
| July 22, 2019 |
DLYT / Dais Analytic Corp. DEF 14C - - DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement DAIS CORPORATION (Name of Registrant |
|
| June 26, 2019 |
DLYT / Dais Analytic Corp. PRE 14C - - PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement DAIS CORPORATION (Name of Registrant |
|
| May 28, 2019 |
Amendment to Certificate of Incorporation. EXHIBIT 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF DAIS CORPORATION Under Section 805 of the Business Corporation Law It is hereby certified that: 1. The name of the corporation is Dais Corporation (the “Corporation”). The name under which it was originally formed is “THE DAIS CORPORATION”. 2. The certificate of incorporation of the Corporation was filed by the New York St |
|
| May 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event Reported): May 22, 2019 DAIS CORPORATION (Exact Name of Registrant as Specified in Charter) New York 000-53554 14-1760865 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 22, 2019 |
DLYT / Dais Analytic Corp. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORP |
|
| May 20, 2019 |
DLYT / Dais Analytic Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS CORPORATION (Exact nam |
|
| May 15, 2019 |
DLYT / Dais Analytic Corp. NT 10-Q NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2019 ¨ |
|
| April 10, 2019 |
DLYT / Dais Analytic Corp. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 000-53554 DAIS CORPORATIO |
|
| April 10, 2019 |
EXHIBIT 3.11 |
|
| April 10, 2019 |
EXHIBIT 10.15 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of August 17, 2015 (the “Effective Date”), by and between: (i) Dais Analytic Corporation, a Florida corporation (the “Company”) and (ii) Brian C. Johnson, an individual (hereinafter referred to as “Employee”). The Company and Employee may be referred to hereinafter individually as a “Party” |
|
| April 9, 2019 |
DLYT / Dais Analytic Corp. DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement DAIS CORPORATION (Name of Registrant |
|
| April 1, 2019 |
DLYT / Dais Analytic Corp. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 000-53554 CUSIP NUMBER (Check one): x Form 10-K o Form 20-F o Form 11-K ¨ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December |
|
| March 26, 2019 |
DLYT / Dais Analytic Corp. PRE 14C PRE 14C 1 dlytpre14c.htm PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement DAI |
|
| February 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 26, 2019 DAIS CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or Organization) ( |
|
| February 28, 2019 |
Certificate of Amendment of the Certificate of Incorporation of Dais Analytic Corporation EXHIBIT 3.1 |
|
| November 30, 2018 |
DLYT / Dais Analytic Corp. DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement DAIS ANALYTIC CORPORATION (Name of R |
|
| November 14, 2018 |
DLYT / Dais Analytic Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2018 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| November 7, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 1, 2018 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or Organiz |
|
| November 5, 2018 |
DLYT / Dais Analytic Corp. PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement DAIS ANALYTIC CORPORATION (Name of R |
|
| August 14, 2018 |
DLYT / Dais Analytic Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2018 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION (E |
|
| May 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2018 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| April 17, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 17, 2018 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or Organizat |
|
| April 17, 2018 |
EXHIBIT 99.1 11552 Prosperous Drive Odessa, FL USA 33556 [email protected] +(1) 727-375-8484 X205 DaisAnalytic.com April 17, 2018 First Name Last Name Address City, State, Zip Country Dear Shareholder, We at Dais recognize and appreciate the continued support of our shareholders. As we are off to a busy start in 2018, we are pleased to share some major business developments demonstrating |
|
| April 2, 2018 |
DLYT / Dais Analytic Corp. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2017 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period from to Commission file number: 000-53554 DAIS ANALYTIC CORPORATION (Exact |
|
| April 2, 2018 |
DLYT / Dais Analytic Corp. / Tangredi Timothy - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Dais Analytic Corporation (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 23302X104 (CUSIP Number) Timothy N. Tangredi 11552 Prosperous Drive Odessa, FL 33556 727-375-8484(X205) With copies to: (Name, Address and Telephone N |
|
| November 14, 2017 |
DLYT / Dais Analytic Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2017 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| August 21, 2017 |
DLYT / Dais Analytic Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2017 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION (E |
|
| August 18, 2017 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 12, 2017 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or Other Jurisdiction of Incorporation or |
|
| August 18, 2017 |
Letter of Mayer Hoffman McCann P.C dated August 16, 2017. dlytex161.htm EXHIBIT 16.1 13577 Feather Sound Drive, Suite 400 n Clearwater, Florida 33762 Main: 727.572.1400 n Fax: 727.571.1933 n www.mhm-pc.com August 16, 2017 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Ladies and Gentlemen, We have read Item 4.01 of Form 8-K dated August 17, 2017 of Dais Analytic Corporation and are in agreement with the statements contained |
|
| August 11, 2017 |
dlytnt10q.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 000-53554 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 11-K x Form 10-Q ? Form N-SAR For Period Ended: June 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR For the Transition Period Ended: Nothing |
|
| May 22, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dlyt10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2017 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-5355 |
|
| May 15, 2017 |
dlytnt10q.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-53554 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 11-K x Form 10-Q ? Form N-SAR For Period Ended: March 31, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR For the Transition Period Ended: Nothin |
|
| April 17, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period from to Commission file number: 000-53554 DAIS ANALYTIC CORPORATION (Exact |
|
| March 31, 2017 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 000-53554 NOTIFICATION OF LATE FILING x Form 10-K ¨ Form 11-K ¨ Form 20-F ¨ Form 10-Q ¨ Form N-SAR For Period Ended: December 31, 2016 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR For the Transition Period Ended: Nothin |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dlyt10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2016 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000- |
|
| November 14, 2016 |
EXHIBIT 10.2 1 2 |
|
| November 14, 2016 |
dlytex101.htm EXHIBIT 10.1 1 2 |
|
| October 28, 2016 |
EXHIBIT 10.1 FIRST AMENDMENT TO SENIOR SECURED PROMISSORY NOTE This First Amendment to the Senior Secured Promissory Note (the “First Amendment to Note”) is made effective the 7th day of September, 2016, (the “Effective Date”) by and between Dais Analytic Corporation, a New York corporation, with its principal office located at 11552 Prosperous Drive, Odessa Florida 33556 (the “Debtor”) and Patric |
|
| October 28, 2016 |
8-K 1 dlyt8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 31, 2016 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of |
|
| August 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dlyt10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2016 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 |
|
| June 28, 2016 |
dlytex101.htm EXHIBIT 10.1 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (the "AGREEMENT"), dated June 24, 2016 ("Effective Date"), is entered into by and between DAIS ANALYTIC CORPORATION, a New York corporation, with its principal place of business located at 11552 Prosperous Drive, Odessa, Florida 33556 ("Debtor") and Patricia Tangredi, who resides at 10416 Pontofino Circle, Trin |
|
| June 28, 2016 |
dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 22, 2016 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or |
|
| June 28, 2016 |
dlytex161.htm EXHIBIT 16.1 June 27, 2016 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on June 22, 2016, to be filed by our former client, Dais Analytic Corporation. We agree with the statements made in response to that Item insofar as they relate to our Firm. Very |
|
| May 16, 2016 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2016 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| March 30, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period fromto Commission file number: 000-53554 DAIS ANALYTIC CORPORATION (Exact |
|
| March 11, 2016 |
Termination of a Material Definitive Agreement dlyt8ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 24, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdic |
|
| February 2, 2016 |
dlytex171.htm EXHIBIT 17.1 February 1, 2016 Dais Analytic Corporation 11552 Prosperous Drive Odessa, Florida 33556 Re; Letter of Resignation To the Board of Directors of Dais Analytic Corporation, Please be advised that I hereby resign from my position as a member of the Board of Directors (the "Board") of Dais Analytic Corporation (the "Company"), effective immediately. My resignation results fro |
|
| February 2, 2016 |
dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2016 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation |
|
| December 31, 2015 |
dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 24, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation |
|
| December 31, 2015 |
EX-10.1 2 dlytex101.htm SHARE EXCHANGE AGREEMENT EXHIBIT 10.1 SHARE EXCHANGE AGREEMENT This SHARE EXCHANGE AGREEMENT (this "Agreement"), dated as of December 24, 2015 but effective as of December 1, 2015, is by and among Dais Analytic Corporation, a New York corporation ("Dais"), Open Systems Control, a California corporation (the "Shareholders"), and Synpower Corporation. Ltd., a Hong Kong corpor |
|
| December 14, 2015 |
SC 13D 1 soec13d.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 DAIS ANALYTIC CORPORATION (Name of Issuer) Common Stock, $.01 par value per share (Title of Class of Securities) 23302X104 (CUSIP Number) Han Shuang Cathay View #5-301 1 Guan Tang East Road Chaoyang District, Beijing 100102, China +86 1380 |
|
| December 11, 2015 |
EX-10.1 2 dlytex101.htm SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 Dais Analytic Corporation Stock Purchase Agreement Modification 1. SPA modification: i. SAGE/JSE (SJ) is relieved of the need to transfer 51% of equity in Dais Beijing. Dais will set-up or acquire its own PRC subsidiary hereinafter referred to as "Dais-China". ii. SJ shall enter into a definitive $60M HVAC AND ENERGY SAVINGS Goods |
|
| December 11, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 7, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation |
|
| November 13, 2015 |
EX-10.34 2 dlytex1034.htm LICENSE AND SUPPLY AGREEMENT EXHIBIT 10.34 |
|
| November 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| October 19, 2015 |
dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 12, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dlyt10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 |
|
| August 14, 2015 |
EXHIBIT 10.40 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is made and entered into as of May 10, 2015 (the ?Effective Date?) by and between: (i) Dais Analytic Corporation, a Florida corporation (the ?Company?) and (ii) Judith M. Aldrovandi, a Florida resident (hereinafter referred to as ?Employee?). The Company and Employee may be referred to hereinafter individually as a ?Pa |
|
| August 4, 2015 |
dlytex161.htm EXHIBIT 16.1 August 1, 2015 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on August 1, 2015, to be filed by our former client, Dais Analytic Corporation. We agree with the statements made in response to that Item insofar as they relate to our Firm. Ver |
|
| August 4, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant dlyt8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-1760865 (State or other jurisdiction of incorporation o |
|
| July 13, 2015 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. |
|
| June 18, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 12, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| April 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| April 1, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period fromto Commission file number: 000-53554 DAIS ANALYTIC CORPORATION (Exact |
|
| April 1, 2015 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-53554 NOTIFICATION OF LATE FILING x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2014 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition R |
|
| March 16, 2015 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organ |
|
| March 5, 2015 |
Certificate of Amendment of the Certificate of Incorporation of Dais Analytic Corporation EX-3.1 2 dlytex31.htm CERTIFICATE OF AMENDMENT EXHIBIT 3.1 CERTIFICATE OF AMENDMENT of THE CERTIFICATE OF INCORPORATION of DAIS ANALYTIC CORPORATION (Pursuant to Section 805 of the Business Corporation Law) It is hereby certified that: 1. The name of the corporation is Dais Analytic Corporation (hereinafter called the “Corporation”). 2. The Corporation’s Certificate of Incorporation was filed by t |
|
| March 5, 2015 |
EXHIBIT 10.1 AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT Amendment to Amended and Restated Employment Agreement (this ?Amendment?), dated effective as of February 27, 2015 (the ?Effective Date?), is entered into by and between Dais Analytic Corporation, a New York corporation (the ?Company?), and Timothy N. Tangredi (the ?Executive? and, together with the Company, the ?Parties?). W I T |
|
| March 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| February 5, 2015 |
DLYT / Dais Analytic Corp. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| February 5, 2015 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2015 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiza |
|
| January 20, 2015 |
DLYT / Dais Analytic Corp. PRER14A - - PRER 14A PRER14A 1 daisprer14a.htm PRER 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment #2) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permi |
|
| January 20, 2015 |
DLYT / Dais Analytic Corp. CORRESP - - January 20, 2015 Ms. Pamela Long Assistant Director United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Dais Analytic Corporation Revised Preliminary Proxy Statement on Schedule 14A Filed December 31, 2014 File No. 0-53554 Dear Ms. Long: This letter is in response to the comments contained in the Securities and Exchange Commission letter, dated January 13, |
|
| January 8, 2015 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SC 13D/A 1 samuelssc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. 5) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 DAIS ANALYTIC CORP. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 23302 |
|
| December 31, 2014 |
DLYT / Dais Analytic Corp. CORRESP - - December 31, 2014 Ms. Pamela Long Assistant Director United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Dais Analytic Corporation Preliminary Proxy Statement on Schedule 14A Filed December 10, 2014 File No. 0-53554 Dear Ms. Long: This letter is in response to the comments contained in the Securities and Exchange Commission letter, dated December 23, 2014 ( |
|
| December 31, 2014 |
DLYT / Dais Analytic Corp. PRER14A - - PRER 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment #1) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definit |
|
| December 22, 2014 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. |
|
| December 19, 2014 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 15, 2014, is made and entered into by and between Dais Analytic Corporation, a New York corporation with its principal executive offices located at 11552 Prosperous Drive, Odessa, Florida 33556 (the “Company”), and Hong Kong SAGE Technology Investment Co., Limited, a Limited Compa |
|
| December 19, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 15, 2014 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| December 10, 2014 |
DLYT / Dais Analytic Corp. PRE 14A - - PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| November 18, 2014 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2014 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| November 12, 2014 |
DLYT / Dais Analytic Corp. 144 - - FORM 144 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 OMB APPROVAL OMB Number: 3235-0101 Expires: May 31, 2017 Estimated average burden hours per response ........... 1.00 SEC USE ONLY DOCUMENT SEQUENCE NO. ATTENTION: Transmit for filing 3 copies of this form concurrently with eit |
|
| November 3, 2014 |
DLYT / Dais Analytic Corp. / SAMUELS LEONARD - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. |
|
| October 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 3, 2014 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizat |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2014 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION (E |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2014 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| May 13, 2014 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a statement on Schedule 13D and all amendments thereto with respect to the Common Stock of Dais Analytic Corporation beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto. |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Dais Analytic Corporation (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 23302X104 (CUSIP Number) Oliver Jimenez Chief Compliance Officer Platinum Management (NY) LLC 152 West 57th Street, 4th Floor New York, New York 10019 |
|
| April 28, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 24, 2014 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizati |
|
| April 28, 2014 |
EXHIBIT 10.1 DISTRIBUTION AGREEMENT This DISTRIBUTION AGREEMENT (the “Agreement”), dated April 24, 2014 is entered into by and between Dais Analytic Corporation, a New York corporation (“Dais”), with an address of 11552 Prosperous Drive, Odessa, FL USA, and SoEX (Hong Kong) Industry & Investment Co., Ltd., a Hong Kong corporation with its registered address at Room 11-2-1103 11/F Kowloon Bldg 555, |
|
| April 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 OMB APPROVAL OMB Number: 3235-0101 Expires: April 30, 2014 Estimated average burden hours per response ........... 2.00 SEC USE ONLY DOCUMENT SEQUENCE NO. ATTENTION: Transmit for filing 3 copies of this form concurrently with e |
|
| April 11, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 OMB APPROVAL OMB Number: 3235-0101 Expires: April 30, 2014 Estimated average burden hours per response ........... 2.00 SEC USE ONLY DOCUMENT SEQUENCE NO. ATTENTION: Transmit for filing 3 copies of this form concurrently with e |
|
| March 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K dlyt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period fromto Commission file number: 000-53554 DAIS ANALYTIC CORPORA |
|
| March 7, 2014 |
Unregistered Sales of Equity Securities - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 3, 2014 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| January 27, 2014 |
EXHIBIT 99.1 Dais Analytic Corporation Initiates Formation of A China Company AND Raises Growth Capital. Dais Analytic Corporation today announced it has entered into an agreement to form a company in China with an industrial partner having existing manufacturing and distribution access to build and more widely promote its Aqualyte™ nanomaterial products to the growing Chinese markets for energy s |
|
| January 27, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 21, 2014 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiza |
|
| January 27, 2014 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 21, 2014, is made and entered into by and between Dais Analytic Corporation, a New York corporation with its principal executive offices located at 11552 Prosperous Drive, Odessa, Florida 33556 (the “Company”), and Soex (Hong Kong) Industry & Investment Co., Ltd., a Hong Kong corpo |
|
| December 27, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 20, 2013 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| December 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 30, 2013 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2013 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| August 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period fromto Commission File No. 000-53554 DAIS ANAL |
|
| August 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period fromto Commission File No. 000-53554 DAIS ANALYTIC CORPORATION (Ex |
|
| July 23, 2013 |
Unregistered Sales of Equity Securities - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 15, 2013 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| June 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 11, 2013 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| June 14, 2013 |
EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), dated June 11, 2013 and in effect as of March 11, 2013 (“Effective Date”), is made by and between Dais Analytic Corporation, a New York Corporation ("Company"), and Joyce Conner-Boyd ("Executive"). RECITALS WHEREAS Company desires to employ and Executive desires to be employed by Company pursuant to the terms and condit |
|
| June 10, 2013 |
DLYT / Dais Analytic Corp. / Tangredi Timothy - SC 13D/A Activist Investment SC 13D/A 1 daissc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Dais Analytic Corporation (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 23302X104 (CUSIP Number) Timothy N. Tangredi 11552 Prosperous Drive Odessa, FL 33556 727-375-8484(X205) With copies |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| March 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 dais10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period fromto Commission file number: 000-53554 DAIS |
|
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 19, 2013 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizati |
|
| December 31, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 28, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| December 31, 2012 |
AMENDMENT TO SECURITIES PURCHASE AGREEMENT EX-10.1 2 daisex101.htm AMENDMENT TO SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 AMENDMENT TO SECURITIES PURCHASE AGREEMENT This Amendment, dated as of December 28, 2012 (this “Amendment”), made and entered into by and between Dais Analytic Corporation, a New York corporation with its principal executive offices located at 11552 Prosperous Drive, Odessa, Florida 33556 (the “Company”), and Green Val |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2012 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| November 5, 2012 |
[***] Designates portions of this document that have been omitted pursuant to a request for confidential treatment filed separately with the Commission. |
|
| November 5, 2012 |
8-K 1 dais8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction o |
|
| November 2, 2012 |
Termination of a Material Definitive Agreement - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiz |
|
| October 23, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 17, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organiza |
|
| October 23, 2012 |
DAIS ANALYTIC CORPORATION and GREEN VALLEY INTERNATIONAL SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 DAIS ANALYTIC CORPORATION and GREEN VALLEY INTERNATIONAL SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 17,2012, is made and entered into by and between Dais Analytic Corporation, a New York corporation with its principal executive offices located at 11552 Prosperous Drive, Odessa, Florida 33556 (the “Company”), and Green Valle |
|
| September 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 30, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizat |
|
| September 6, 2012 |
EXHIBIT 99.1 |
|
| August 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Amendment No. 1) 10-Q/A 1 dlyt10qa.htm FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Amendment No. 1) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2012 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commis |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2012 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION (E |
|
| July 24, 2012 |
SC 13D/A 1 formsc13da.htm PLATINUM-MONTAUR LIFE SCIENCES LLC SC13DA 3-22-2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Dais Analytic Corporation (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 23302X104 (CUSIP Number) Oliver Jimenez Chief Compliance Officer Platinu |
|
| July 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 13, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| July 19, 2012 |
EXHIBIT 10.2 PATENT SECURITY AGREEMENT This PATENT SECURITY AGREEMENT (this “Agreement”) is made on this 13th day of July, 2012 between Dais Analytic Corporation ("Debtor"), and holder of Secured Convertible Promissory Note dated July 13, 2012 ("Secured Party"). 1. SECURITY INTEREST. Debtor hereby grants to Secured Party a security interest in (i) all rights, title, and interest in all patents, pa |
|
| July 19, 2012 |
DAIS ANALYTIC CORPORATION SECURED CONVERTIBLE PROMISSORY NOTE $ 2,000,000 Dated: July 13, 2012 EXHIBIT 10.1 THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THAT ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT AN EXEMPTION FROM REGISTRATION THEREUNDER IS AVAILABLE. DAIS ANALYTIC CORPORATION SECURED CONVERTIBLE |
|
| June 21, 2012 |
DAIS ANALYTIC CORPORATION 11552 PROSPEROUS DRIVE ODESSA, FL 33556 June 15, 2012 EXHIBIT 10.1 DAIS ANALYTIC CORPORATION 11552 PROSPEROUS DRIVE ODESSA, FL 33556 June 15, 2012 Platinum-Montaur Life Sciences LLC 152 West 57th Street, 4th Floor New York, New York 10019 Ladies and Gentlemen: On March 22, 2011 Dais Analytic Corporation (the “Company”) delivered to Platinum-Montaur Life Sciences, LLC (“Platinum”): (i) the Amended and Restated Convertible Promissory Note dated March 2 |
|
| June 21, 2012 |
Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizati |
|
| June 18, 2012 |
Dais Analytic Corporation 11552 Prosperous Drive Odessa, FL 33556 June 18, 2012 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| May 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2012 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organizatio |
|
| May 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2012 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATION ( |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 dlyt10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period fromto Commission file number: 000-53554 DAIS |
|
| March 30, 2012 |
AMENDMENT TO AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE Exhibit 4.41 AMENDMENT TO AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This AMENDMENT TO THE AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE is dated as of March 20, 2012, by and between Dais Analytic Corporation, a New York corporation (the ?Company?), and Platinum-Montaur Life Sciences, LLC (?Platinum?), a Delaware limited liability company. WHEREAS, the Company issued to Platinum the Amend |
|
| March 30, 2012 |
AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTE Exhibit 4.40 AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTE This AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTE is dated as of March 20, 2012, by and between Dais Analytic Corporation, a New York corporation (the ?Company?), and Platinum-Montaur Life Sciences, LLC (?Platinum?), a Delaware limited liability company. WHEREAS, the Company issued to Platinum the Secured Convertible Promissory Note |
|
| March 30, 2012 |
AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT EX-10.29 4 dlytex1029.htm AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT Exhibit 10.29 AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT This AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT is dated February 27, 2012, by and between Dais Analytic Corporation, a New York corporation (the “Company”), and Timothy N. Tangredi (“Executive”). WHEREAS, the Company and Executive are parties to an Executive Compe |
|
| March 6, 2012 |
DATED March 6, 2012 40,000,000 Shares of Common Stock Filed pursuant to Rule 424(b)(1) Registration No. 333-176894 DATED March 6, 2012 PROSPECTUS 40,000,000 Shares of Common Stock This is a public offering of up to 40,000,000 shares of our common stock. The public offering price for the common stock offered hereby is $0.26 per share. The common stock offering price will remain fixed for the duration of the offering. Our common stock is quoted on the |
|
| February 10, 2012 |
As filed with the Securities and Exchange Commission on February 10, 2012 Registration No. |
|
| February 10, 2012 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about February 10, 2012. February 10, 2012 By: /s/ Peter Termyn Peter Termyn |
|
| February 10, 2012 |
DAIS ANALYTIC CORPORATION February 10, 2012 Filed as Correspondence Via EDGAR Pamela Long Assistant Director United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| February 8, 2012 |
As filed with the Securities and Exchange Commission on February 8 , 2012 Registration No. |
|
| February 8, 2012 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about February 8, 2012. February 8, 2012 By: /s/ Peter Termyn Peter Termyn |
|
| February 1, 2012 |
RICHARDSON & PATEL LLP January 27, 2012 Submitted via EDGAR as Correspondence Ms. Jessica Dickerson Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Dais Analytic Corporation Amendment No. 4 to Registration Statement on Form S-1 File No. 333-176894 Dear Ms. Dickerson: On behalf of Dais Analytic Corporation, (the “Company”), set forth be |
|
| January 27, 2012 |
As filed with the Securities and Exchange Commission on January 27 , 2012 Registration No. |
|
| January 27, 2012 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about January 27, 2012. January 27, 2012 By: /s/ Peter Termyn Peter Termyn |
|
| January 13, 2012 |
EX-10.28 3 dlytex1028.htm EXECUTIVE COMPENSATION AGREEMENT EXHIBIT 10.28 EXECUTIVE COMPENSATION AGREEMENT THIS EXECUTIVE COMPENSATION AGREEMENT (the “Agreement”) is made and entered into as of the 11th day of January 2012 (“Effective Date”) by and between DAIS ANALYTIC CORPORATION, a New York Corporation (“Company”), and TIMOTHY N. TANGREDI (“Executive”). R E C I T A L S WHEREAS, the Company and E |
|
| January 13, 2012 |
As filed with the Securities and Exchange Commission on January 13 , 201 2 Registration No. |
|
| January 13, 2012 |
EX-99.1 5 dlytex991.htm CONSENT OF TERMYN EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about January 13, 2012. January 13, 2012 By: /s/ Peter Termyn Peter Termyn |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2011 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS ANALYTIC CORPORATI |
|
| November 2, 2011 |
EXHIBIT 99.2 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1/A to be filed with the Securities and Exchange Commission on or about November 2 , 2011. November 2 , 2011 By: /s/Richard Rutkowski Richard Rutkowski |
|
| November 2, 2011 |
As filed with the Securities and Exchange Commission on November 2 , 2011 Registration No. |
|
| November 2, 2011 |
RICHARDSON & PATEL LLP November 2, 2011 Submitted via EDGAR as Correspondence Ms. Jessica Dickerson Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Dais Analytic Corporation Amendment No. 2 to Registration Statement on Form S-1 File No. 333-176894 Dear Ms. Dickerson: On behalf of Dais Analytic Corporation, (the “Company”), set forth be |
|
| November 2, 2011 |
EXHIBIT 99.3 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1/A to be filed with the Securities and Exchange Commission on or about November 2 , 2011. November 2 , 2011 By: /s/ Peter Termyn Peter Termyn |
|
| November 2, 2011 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about November 2, 2011 November 2 , 2011 By: /s/ Lon S. Bell Lon Bell |
|
| October 13, 2011 |
EXHIBIT 4.26 FORM OF UNDERWRITER WARRANT THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECUR |
|
| October 13, 2011 |
EX-99.3 8 dlytex993.htm CONSENT OF DIRECTOR NOMINEE EXHIBIT 99.3 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1/A to be filed with the Securities and Exchange Commission on or about October 13, 2011. October 13, 2011 By: /s/ Peter Termyn Peter Termyn |
|
| October 13, 2011 |
DAIS ANALYTIC CORPORATION UNDERWRITING AGREEMENT EX-1.1 2 dlytex11.htm UNDERWRITING AGREEMENT EXHIBIT 1.1 DAIS ANALYTIC CORPORATION UNDERWRITING AGREEMENT Los Angeles, California October , 2011 MDB Capital Group, LLC 401 Wilshire Blvd., Suite 1020 Santa Monica, CA 90401 Ladies and Gentlemen: The undersigned, Dais Analytic Corporation, a New York corporation (the “Company”), hereby confirms its agreement with MDB Capital Group, LLC (hereinafter r |
|
| October 13, 2011 |
As filed with the Securities and Exchange Commission on October 13 , 2011 Registration No. |
|
| October 13, 2011 |
EXHIBIT 99.2 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1/A to be filed with the Securities and Exchange Commission on or about October 13, 2011. October 13, 2011 By: /s/Richard Rutkowski Richard Rutkowski |
|
| October 13, 2011 |
RICHARDSON & PATEL LLP October 13, 2011 Submitted via EDGAR as Correspondence Ms. Jessica Dickerson Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Dais Analytic Corporation Amendment No. 1 to Registration Statement on Form S-1 Filed September 19, 2011 File No. 333-176894 Dear Ms. Dickerson: On behalf of Dais Analytic Corporation, (the |
|
| October 13, 2011 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1/A to be filed with the Securities and Exchange Commission on or about October 13, 2011. October 13, 2011 By: /s/ Lon S. Bell Lon Bell |
|
| October 12, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOWN ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Timothy N. |
|
| October 12, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOWN ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Timothy N. |
|
| October 12, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOWN ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Timothy N. |
|
| October 12, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOWN ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Timothy N. |
|
| October 12, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOWN ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Timothy N. |
|
| September 19, 2011 |
EXHIBIT 99.3 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about September 13, 2011. September 13, 2011 By: /s/ Peter Termyn Peter Termyn |
|
| September 19, 2011 |
EX-1.1 2 dlytex11.htm UNDERWRITING AGREEMENT EXHIBIT 1.1 UNDERWRITING AGREEMENT between DAIS ANALYTIC CORPORATION and MDB CAPITAL GROUP, LLC as Underwriter DAIS ANALYTIC CORPORATION UNDERWRITING AGREEMENT Los Angeles, California, 2011 MDB Capital Group, LLC401 Wilshire Blvd., Suite 1020Santa Monica, CA 90401 Ladies and Gentlemen: The undersigned, Dais Analytic Corporation, a New York corporation ( |
|
| September 19, 2011 |
EXHIBIT 10.26 EXECUTIVE COMPENSATION AGREEMENT THIS EXECUTIVE COMPENSATION AGREEMENT (the ?Agreement?) is made and entered into as of the 14 th day of September 2011 (?Effective Date?) by and between DAIS ANALYTIC CORPORATION, a New York Corporation (?Company?), and TIMOTHY N. TANGREDI (?Executive?). R E C I T A L S WHEREAS, the Company and Executive are parties to an amended and restated employme |
|
| September 19, 2011 |
As filed with the Securities and Exchange Commission on September 19, 2011 Registration No. |
|
| September 19, 2011 |
EX-99.1 5 dlytex911.htm CONSENT OF LON BELL EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about September 13, 2011. September 3, 2011 By: /s/ Lon S. Bell Lon Bell |
|
| September 19, 2011 |
EXHIBIT 99.2 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission on or about September 13, 2011. September 3, 2011 By: /s/Richard Rutkowski Richard Rutkowski |
|
| September 15, 2011 |
8-K 1 dais8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2011 DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction |
|
| September 15, 2011 |
EXHIBIT 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the ?Agreement?) is made and entered into as of the 14th day of September 2011 (?Effective Date?) by and between Dais Analytic Corporation, a New York Corporation (?Company?), and Timothy N. Tangredi (?Executive?). RECITALS WHEREAS, Executive entered into an employment agreement with Company date |
|
| August 12, 2011 |
Dais Analytic Corporation 11552 Prosperous Drive Odessa, FL 33556 August 12, 2011 Dais Analytic Corporation 11552 Prosperous Drive Odessa, FL 33556 August 12, 2011 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| August 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A (Amendment No. 2) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2011 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 DAIS AN |
|
| August 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dais10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2011 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-53554 |
|
| August 10, 2011 |
10-Q/A 1 dais10q.htm FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q /A (Amendment No. 1) x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2011 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Comm |
|
| July 6, 2011 |
AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] PATENT SECURITY AGREEMENT Exhibit 10.10 [CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] PATENT SECURITY AGREEMENT This PATENT SECURITY AGREEMENT (this ?Agreement?) is made on this 22nd day of March, 2011 between Dais Analytic Corporation ("Debtor"), and Platinum-Montaur Life Sciences, LLC ("Secured Party" |
|
| July 6, 2011 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): (March 23, 2011) DAIS ANALYTIC CORPORATION (Exact name of registrant as specified in its charter) New York 000-53554 14-760865 (State or other jurisdiction of incorporation or organ |
|
| July 6, 2011 |
Exhibit 10.7 [CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELYWITH THE SECURITIES AND EXCHANGE COMMISSION.] NOTE AND WARRANT PURCHASE AGREEMENT This NOTE AND WARRANT PURCHASE AGREEMENT, dated as of March 22, 2011, (this ?Agreement?) is entered into by and between Dais Analytic Corporation, a New York corporation (?Company?), w |
|
| June 22, 2011 |
EXHIBIT 99.1 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 filed with the Securities and Exchange Commission. June 10, 2011 By: /s/ Lon Bell Lon Bell |
|
| June 22, 2011 |
EXECUTIVE COMPENSATION AGREEMENT EX-10.25 3 daisex1025.htm EXECUTIVE COMPENSATION AGREEMENT EXHIBIT 10.25 EXECUTIVE COMPENSATION AGREEMENT THIS EXECUTIVE COMPENSATION AGREEMENT (the “Agreement”) is made and entered into as of the 17th day of June 2011 (“Effective Date”) by and between DAIS ANALYTIC CORPORATION, a New York Corporation (“Company”), and TIMOTHY N. TANGREDI (“Executive”). R E C I T A L S WHEREAS, the Company and Exec |
|
| June 22, 2011 |
As filed with the Securities and Exchange Commission on June 21 , 2011 Registration No. |
|
| June 22, 2011 |
UNDERWRITING AGREEMENT DAIS ANALYTIC CORPORATION MDB CAPITAL GROUP, LLC as Underwriter EXHIBIT 1.1 UNDERWRITING AGREEMENT between DAIS ANALYTIC CORPORATION and MDB CAPITAL GROUP, LLC as Underwriter 1 DAIS ANALYTIC CORPORATION UNDERWRITING AGREEMENT Los Angeles, California, 2011 MDB Capital Group, LLC401 Wilshire Blvd., Suite 1020 Santa Monica, CA 90401 Ladies and Gentlemen: The undersigned, Dais Analytic Corporation, a New York corporation (the ?Company?), hereby confirms its agreem |
|
| June 22, 2011 |
EXHIBIT 99.2 CONSENT OF DIRECTOR NOMINEE I hereby consent to being named as a nominee to the Board of Directors of Dais Analytic Corporation, a New York corporation, in its Registration Statement on Form S-1 filed with the Securities and Exchange Commission. June 10, 2011 By: /s/ Richard Rutkowski Richard Rutkowski |
|
| June 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A 10-Q/A 1 dais10qa.htm FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2011 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 0 |
|
| June 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A 10-K/A 1 dais10ka.htm FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2010 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934 For the transition period from to Commission file number: 000-53 |
